Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
Claus Garbe(University Children's Hospital Tübingen), John M. Kirkwood(UPMC Hillman Cancer Center)
Cited by 579
Related Papers
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134
|Journal of Clinical Oncology|2022|427
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
|PLoS ONE|2014|309
Modulation of Signal Transducers and Activators of Transcription 1 and 3 Signaling in Melanoma by High-Dose IFNα2b
|Clinical Cancer Research|2007|110